Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro-Reference-Cited by-同舟云学术

Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro

Published:2009-02-13 Issue:10 Volume:58 Page:1647-1655
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Liu Wujiang,O’Donnell Michael A.,Chen Xiaohong,Han Ruifa,Luo Yi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-009-0673-z.pdf

Reference49 articles.

1. Lamm DL, Thor DE, Harris SC, Reyna JA, Stogdill VD, Radwin HM (1980) Bacillus Calmette-Guérin immunotherapy of superficial bladder cancer. J Urol 124:38–40

2. O’Donnell MA, DeWolf DC (1995) Bacillus Calmette-Guérin immunotherapy for superficial bladder cancer. New prospects for an old warhorse. Surg Oncol Clin N Am 4:189–202

3. Alexandroff AB, Jackson AM, O’Donnell MA, James K (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353:1689–1694

4. Bohle A, Gerdes J, Ulmer AJ, Hofstetter AG, Flad HD (1990) Effects of local bacillus Calmette-Guérin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J Urol 144:53–58

5. Prescott S, James K, Hargreave TB, Chisholm GD, Smyth JF (1992) Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol 147:1636–1642

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycobacterium bovis BCG reverses deleterious effects of H. pylori components towards gastric barrier cells in vitro;Biomedicine & Pharmacotherapy;2024-09

2. Recombinant BCG to Enhance Its Immunomodulatory Activities;Vaccines;2022-05-23

3. Gmcsf and Ifnα gene therapy improves the response to BCG immunotherapy in a murine model of bladder cancer;Future Oncology;2020-06

4. Recombinant Bacillus Calmette-Guérin for Mucosal Immunity;Mucosal Vaccines;2020

5. In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment;Frontiers in Immunology;2019-06-26